Fatal and Near-Fatal Anaphylaxis: Data From the European Anaphylaxis Registry and National Health Statistics

Veronika Höfer(Humboldt-Universität zu Berlin), Margitta Worm(Charité - Universitätsmedizin Berlin), Claudia Pföhler(Saarland University), Bettina Wedi(Medizinische Hochschule Hannover), Regina Treudler(Humboldt-Universität zu Berlin), Victòria Cardona(Vall d'Hebron Hospital Universitari), Luís Felipe Ensina(Universidade Federal de São Paulo), Franziska Ruëff(LMU Klinikum), Wojciech Francuzik(Charité - Universitätsmedizin Berlin), Anne Moeser(Jena University Hospital), D. Sabouraud-Leclerc(Centre Hospitalier Universitaire de Reims), Karin Hartmann(University Hospital of Basel), Sabine Dölle(Freie Universität Berlin), Nicola Wagner(Friedrich-Alexander-Universität Erlangen-Nürnberg)
The Journal of Allergy and Clinical Immunology In Practice
October 9, 2023
10.1016/j.jaip.2023.09.044
Cited by 33

Related Papers

Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
|New England Journal of Medicine|2016|2.1k
The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria
|Allergy|2018|1.5k
EAACI Food Allergy and Anaphylaxis Guidelines: diagnosis and management of food allergy
|Allergy|2014|1.4k
The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria
|Allergy|2021|1.2k
The <scp>EAACI</scp>/<scp>GA</scp><sup>2</sup><scp>LEN</scp>/<scp>EDF</scp>/<scp>WAO</scp> Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update
|Allergy|2014|1.2k